By Colin Kellaher The Food and Drug Administration has officially pulled its authorization of the anticancer drug Pepaxto from Swedish biotech Oncopeptides..
By David Winning SYDNEY Sonic Healthcare said its net profit fell by 47% on a steep drop in Covid-19 testing volumes, but it has benefited from recent.
By Sabela Ojea Shares of Monopar Therapeutics on Tuesday rose sharply after the company said it received clearance in Australia to begin a phase 1 dosimetry.
By Will Feuer Laboratory Corporation of America reported higher fourth-quarter revenue, lifted by strength in its core business that offset softening sales.